https://www.selleckchem.com/products/ng25.html
7% and 84.6%, respectively; p = 0.002). Within the steroid group, the incidence of developing secondary complications was also markedly lower than that in the non-steroid group. Conclusions In patients afflicted with non-severe COVID-19, the employment of low-dose, short-course corticosteroids may confer a therapeutic advantage, significantly curtailing the mortality rate, the length of hospital stay, and the risk of developing secondary complications. Irritable bowel syndrome (IBS) is a chronic and debilitating functional gastrointestinal
Like
Comment
Share
